Page last updated: 2024-08-23

bromocriptine and Tricuspid Incompetence

bromocriptine has been researched along with Tricuspid Incompetence in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Au, WL; Chan, YH; Lee, RK; Ng, KK; Tan, LC; Tan, NC1
Abad, A; Aller, J; Batista, E; Doltra, A; García-Pavía, P; Halperin, I; Lucas, T; Mirelis, JG; Mora, M; Puig-Domingo, M; Santos, AE; Sitges, M; Varela, C1

Other Studies

2 other study(ies) available for bromocriptine and Tricuspid Incompetence

ArticleYear
Bromocriptine use and the risk of valvular heart disease.
    Movement disorders : official journal of the Movement Disorder Society, 2009, Feb-15, Volume: 24, Issue:3

    Topics: Aged; Aortic Valve Insufficiency; Bromocriptine; Dopamine Agonists; Dose-Response Relationship, Drug; Echocardiography, Doppler; Female; Heart Valve Diseases; Humans; Male; Mitral Valve Insufficiency; Parkinson Disease; Receptor, Serotonin, 5-HT2B; Risk Factors; Severity of Illness Index; Tricuspid Valve Insufficiency

2009
No clinically significant valvular regurgitation in long-term cabergoline treatment for prolactinoma.
    Clinical endocrinology, 2012, Volume: 77, Issue:2

    Topics: Adolescent; Adult; Antineoplastic Agents; Bromocriptine; Cabergoline; Cross-Sectional Studies; Echocardiography; Ergolines; Female; Humans; Male; Middle Aged; Prolactinoma; Retrospective Studies; Tricuspid Valve Insufficiency; Young Adult

2012